Press Release Archive
2007 | 2006 | 2005 | 2004 | 2003 | 2002
Memory Pharmaceuticals Closes Second Tranche of $32.2 Million Financing
Memory Pharmaceuticals Corp. Press Release
December 18, 2006
Memory Pharmaceuticals Announces Release of Clinical Hold on MEM 3454
Memory Pharmaceuticals Corp. Press Release
December 11, 2006
Memory Pharmaceuticals Presents Data for MEM 3454 and MEM 1003 at the American
College of Neuropsychopharmacology Annual Meeting
Memory Pharmaceuticals Corp. Press Release
December 7, 2006
Memory Pharmaceuticals Completes Enrollment for MEM 1003 Bipolar Trial
Memory Pharmaceuticals Corp. Press Release
November 27, 2006
Memory Pharmaceuticals Earns Milestone Payment for Phase 2a Trial of MEM 1003 in
Bipolar Disorder
Memory Pharmaceuticals Corp. Press Release
November 20, 2006
Memory Pharmaceuticals Reports Third Quarter 2006 Financial Results
Memory Pharmaceuticals Corp. Press Release
November 9, 2006
Memory Pharmaceuticals to Announce Third Quarter 2006 Results on Thursday, November
9, 2006
Memory Pharmaceuticals Corp. Press Release
November 2, 2006
Memory Pharmaceuticals Announces November 2006 Conference Presentations
Memory Pharmaceuticals Corp. Press Release
November 1, 2006
Memory Pharmaceuticals to Receive $2 Million Milestone from Roche Related to MEM
3454
Memory Pharmaceuticals Corp. Press Release
October 31, 2006
Memory Pharmaceuticals Provides Update on Phase 2a Trial of MEM 3454 in Alzheimer's
Disease
Memory Pharmaceuticals Corp. Press Release
October 16, 2006
Memory Pharmaceuticals Announces $32.2 Million Financing
Memory Pharmaceuticals Corp. Press Release
October 5, 2006
Memory Pharmaceuticals Achieves Milestone in PDE10 Collaboration With Amgen
Memory Pharmaceuticals Corp. Press Release
September 28, 2006
Memory Pharmaceuticals Initiates Phase 2a Trial of MEM 1003 in Bipolar
Disorder
Memory Pharmaceuticals Corp. Press Release
September 5, 2006
Memory Pharmaceuticals Reports Second Quarter 2006 Financial Results
Memory Pharmaceuticals Corp. Press Release
August 9, 2006
Memory Pharmaceuticals to Announce Second Quarter 2006 Results on Wednesday, August
9, 2006
Memory Pharmaceuticals Corp. Press Release
August 2, 2006
Memory Pharmaceuticals Achieves Milestone Under Nicotinic Alpha-7 Collaboration With
Roche
Memory Pharmaceuticals Corp. Press Release
July 17, 2006
Memory Pharmaceuticals to Present at the Needham & Company Fifth Annual BioTechnology
and Medical Technology Conference
Memory Pharmaceuticals Corp. Press Release
June 8, 2006
Memory Pharmaceuticals Provides Update on MEM 3454 Program
Memory Pharmaceuticals Corp. Press Release
June 1, 2006
Memory Pharmaceuticals to Present at the Bank of America Health Care Conference
2006
Memory Pharmaceuticals Corp. Press Release
May 11, 2006
Memory Pharmaceuticals Reports First Quarter 2006 Financial Results
Memory Pharmaceuticals Corp. Press Release
May 11, 2006
Memory Pharmaceuticals to Announce First Quarter 2006 Results on Thursday, May 11,
2006
Memory Pharmaceuticals Corp. Press Release
May 4, 2006
Memory Pharmaceuticals to Host R&D Day on April 21, 2006
Memory Pharmaceuticals Corp. Press Release
April 14, 2006
Memory Pharmaceuticals to Present at CIBC World Markets Annual Biotechnology &
Specialty Pharmaceuticals Conference
Memory Pharmaceuticals Corp. Press Release
March 29, 2006
Memory Pharmaceuticals to Present at SG Cowen Healthcare Conference
Memory Pharmaceuticals Corp. Press Release
February 28, 2006
Memory Pharmaceuticals Expands Roche Nicotinic Alpha-7 Alliance
Memory Pharmaceuticals Corp. Press Release
February 27, 2006
Memory Pharmaceuticals Announces Positive Preliminary Phase 1 Cognitive Data for MEM 3454
Memory Pharmaceuticals Corp. Press Release
February 21, 2006
Memory Pharmaceuticals Reports Fourth Quarter and Full Year 2005 Financial Results
Memory Pharmaceuticals Corp. Press Release
February 21, 2006
Memory Pharmaceuticals to Announce Fourth Quarter and Full Year 2005 Results on Tuesday, February 21, 2006
Memory Pharmaceuticals Corp. Press Release
February 14, 2006
Memory Pharmaceuticals Completes Dosing of Phase 1 Study of MEM 3454
Memory Pharmaceuticals Corp. Press Release
February 14, 2006